PHARMA HELSE AS
Organization
- CEO
- TC
- Chairman of the board
- TC
- Years since formation
- 5 years
- since Jun 30, 2020
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 9,000
- 1 share class
- Total number of shareholders
- 5
- persons
Financials
- Total operating income 2024
- 6,134,221
- NOK
- Annual total result 2024
- -887,856
- NOK
- Total equity 2024
- -264,278
- NOK
Last update: Sep 9, 2025
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
TC | Managing Director/CEO | 23.67 % directly |
Board
| Name | Role | Shares |
|---|---|---|
TC | Chairman | 23.67 % directly |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
LI 1987 | - | 23.67 % directly |
IA 1977 | - | 23.67 % directly |
TC | Managing Director/CEO, Chairman | 23.67 % directly |
KI 1985 | - | 15 % directly |
MI 1982 | - | 14 % directly |
Last update: Dec 10, 2024
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
IA 1977 | Ordinary shares | 2,130 | 23.67 % |
LI 1987 | Ordinary shares | 2,130 | 23.67 % |
TC | Ordinary shares | 2,130 | 23.67 % |
KI 1985 | Ordinary shares | 1,350 | 15 % |
MI 1982 | Ordinary shares | 1,260 | 14 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 6,134,221 | 2,543,772 | 1,487,508 | 32,042 |
Annual Total Result | -887,856 | 439,656 | -438,308 | -221,655 |
Total assets | 2,035,940 | 2,194,792 | 368,849 | 250,815 |
Total liabilities | 2,300,218 | 1,571,214 | 984,926 | 428,584 |
Total equity | -264,278 | 623,578 | -616,078 | -177,770 |
P&L
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 6,134,221 | 2,543,772 | 1,487,508 | 32,042 |
Total operating costs | 6,743,444 | 1,965,949 | 1,921,128 | 253,713 |
Operating result | -609,223 | 577,822 | -433,620 | -221,671 |
Financial income/costs | -278,633 | -138,166 | -4,688 | 16 |
Profit before tax | -887,856 | 439,656 | -438,308 | -221,655 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 0 |
Annual Total Result | -887,856 | 439,656 | -438,308 | -221,655 |
Balance overview
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total fixed assets | 15,750 | 15,750 | 15,750 | 0 |
Total current assets | 2,020,190 | 2,179,042 | 353,099 | 250,815 |
Total assets | 2,035,940 | 2,194,792 | 368,849 | 250,815 |
Short term debt | 1,521,106 | 524,155 | 650,161 | 16,009 |
Long term debt | 779,112 | 1,047,059 | 334,765 | 412,576 |
Total liabilities | 2,300,218 | 1,571,214 | 984,926 | 428,584 |
Contributed capital | 900,000 | 900,000 | 100,000 | 100,000 |
Retained earnings | -1,164,278 | -276,422 | -716,078 | -277,770 |
Total equity | -264,278 | 623,578 | -616,078 | -177,770 |
Total equity and liabilities | 2,035,940 | 2,194,792 | 368,848 | 250,815 |
Classification
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises